Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 30, 2024
Apr. 01, 2023
Current assets    
Cash and equivalents $ 674,605 $ 814,887
Accounts receivable, less allowance for doubtful accounts of: March 2024 - $26,369; March 2023 - $28,075 1,273,965 1,610,295
Inventories 1,766,366 2,292,790
Other current assets 512,011 434,737
Total current assets 4,226,947 5,152,709
Property, plant and equipment: 823,886 942,440
Intangible assets, net 2,628,482 2,642,821
Goodwill 1,460,414 1,978,413
Operating lease right-of-use assets 1,330,361 1,372,182
Other assets 1,142,873 1,901,923
TOTAL ASSETS 11,612,963 13,990,488
Current liabilities    
Short-term borrowings 263,938 11,491
Current portion of long-term debt 1,000,721 924,305
Accounts payable 817,128 936,319
Accrued liabilities 1,375,192 1,673,651
Total current liabilities 3,456,979 3,545,766
Long-term debt 4,702,284 5,711,014
Operating lease liabilities 1,156,858 1,171,941
Other liabilities 638,477 651,054
Total liabilities 9,954,598 11,079,775
Commitments and contingencies
Stockholders' equity    
Preferred Stock, par value $1; shares authorized, 25,000,000; no shares outstanding at March 2024 or March 2023 0 0
Common Stock, stated value $0.25; shares authorized, 1,200,000,000; shares outstanding at March 2024 - 388,836,219; March 2023 - 388,665,531 97,209 97,166
Additional paid-in capital 3,600,071 3,775,979
Accumulated other comprehensive loss (1,064,331) (1,019,518)
Retained earnings (accumulated deficit) (974,584) 57,086
Total stockholders’ equity 1,658,365 2,910,713
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 11,612,963 $ 13,990,488